Traws Pharma, Inc. Increase (Decrease) in Other Noncurrent Assets
Traws Pharma, Inc. (TRAW) reported Increase (Decrease) in Other Noncurrent Assets of -$5.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-14
- Traws Pharma, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $0.00.
- Traws Pharma, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$5.00K, a 102.54% decline year-over-year.
- Traws Pharma, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-03-31 was $197.00K.
- Traws Pharma, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2022-12-31 was $0.00.
- Traws Pharma, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was -$9.00K.
- Traws Pharma, Inc. increase (decrease) in other noncurrent assets for fiscal 2019 was $1.00K, a 99.27% decline from fiscal 2018.
- Traws Pharma, Inc. increase (decrease) in other noncurrent assets for fiscal 2018 was $137.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$5.00K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | -$5.00K 10-Q · filed 2026-05-15 | |||
| 2025-03-31 | $197.00K 10-Q · filed 2026-05-15 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$9.00K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | -$9.00K 10-Q · filed 2023-11-14 | |||
| 2021-09-30 | -$128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$138.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$10.00K 10-Q · filed 2022-08-15 | |||
| 2019-12-31 | $1.00K 10-K · filed 2020-03-27 | |||
| 2018-12-31 | $137.00K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |